Literature DB >> 10675357

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

K Cusi1, K Maezono, A Osman, M Pendergrass, M E Patti, T Pratipanawatr, R A DeFronzo, C R Kahn, L J Mandarino.   

Abstract

The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675357      PMCID: PMC377440          DOI: 10.1172/JCI7535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

Authors:  R STEELE; J S WALL; R C DE BODO; N ALTSZULER
Journal:  Am J Physiol       Date:  1956-09

2.  Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.

Authors:  M Björnholm; Y Kawano; M Lehtihet; J R Zierath
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

3.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

Authors:  D Worm; J Vinten; P Staehr; J E Henriksen; A Handberg; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

4.  Immune complex kinase assays for mitogen-activated protein kinase and MEK.

Authors:  C W Reuter; A D Catling; M J Weber
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.

Authors:  R C Bonadonna; S Del Prato; E Bonora; M P Saccomani; G Gulli; A Natali; S Frascerra; N Pecori; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

Review 6.  New insights into the role and mechanism of glycogen synthase activation by insulin.

Authors:  J C Lawrence; P J Roach
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

7.  4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.

Authors:  M E Patti; X J Sun; J C Bruening; E Araki; M A Lipes; M F White; C R Kahn
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

8.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.

Authors:  G Perseghin; T B Price; K F Petersen; M Roden; G W Cline; K Gerow; D L Rothman; G I Shulman
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

9.  Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin.

Authors:  J Dorrestijn; D M Ouwens; N Van den Berghe; J L Bos; J A Maassen
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

10.  Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Authors:  A Dunaif; J Xia; C B Book; E Schenker; Z Tang
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  286 in total

Review 1.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Euglena gracilis deoxyribonucleic acid polymerases: subcellular locations and variations during the cell cycle.

Authors:  A G McLennan; H M Keir
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

3.  Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats.

Authors:  H G Zecchin; R M N Bezerra; J B C Carvalheira; M A Carvalho-Filho; K Metze; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

4.  Prevention of hyperglycemic signal pathways in metabolic syndrome carotid artery of rats.

Authors:  Hiromi Kawai; Fengfeng Tian; Tomoko Kurata; Kentaro Deguchi; Toru Yamashita; Yoshio Omote; Syoichiro Kono; Koji Abe
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

5.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 6.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 7.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 8.  Advanced-glycation end products in insulin-resistant states.

Authors:  Georgia Soldatos; Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 9.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

Review 10.  Cardiovascular fitness and type 2 diabetes.

Authors:  Cathy Mullooly
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.